Bayer Stock Price, News & Analysis (OTCMKTS:BAYRY)

$32.05 0.23 (0.72 %)
(As of 01/21/2018 01:21 AM ET)
Previous Close$32.05
Today's Range$31.79 - $32.09
52-Week Range$26.98 - $35.41
Volume577,546 shs
Average Volume377,529 shs
Market Capitalization$105.24 billion
P/E RatioN/A
Dividend Yield1.69%
Beta1.12

About Bayer (OTCMKTS:BAYRY)

Bayer logoBayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BAYRY
CUSIPN/A
Phone49-21-4-30-1

Debt

Debt-to-Equity Ratio0.67%
Current Ratio1.51%
Quick Ratio1.01%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio14.98
P/E Growth1.82

Sales & Book Value

Annual Sales$51.77 billion
Price / Sales2.05
Cash Flow$3.23 per share
Price / Cash9.93
Book Value$10.67 per share
Price / Book3.00

Profitability

Trailing EPSN/A
Net Income$5.01 billion
Net Margins10.88%
Return on Equity18.53%
Return on Assets6.81%

Miscellaneous

Employees115,200
Outstanding Shares3,307,800,000

Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How often does Bayer pay dividends? What is the dividend yield for Bayer?

Bayer announced an annual dividend on Thursday, June 29th. Investors of record on Wednesday, May 3rd will be given a dividend of $2.157 per share on Monday, May 15th. The ex-dividend date is Monday, May 1st. View Bayer's Dividend History.

How were Bayer's earnings last quarter?

Bayer AG (OTCMKTS:BAYRY) announced its quarterly earnings data on Thursday, October, 26th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.29 by $0.14. Bayer had a net margin of 10.88% and a return on equity of 18.53%. View Bayer's Earnings History.

When will Bayer make its next earnings announcement?

Bayer is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Bayer.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:

  • Werner Wenning, Chairman of the Supervisory Board (Age 71)
  • Werner Baumann, Chairman of the Management Board, Chief Executive Officer (Age 54)
  • Oliver Zuehlke, Vice Chairman of the Supervisory Board, Employee Representative (Age 48)
  • Johannes M. Dietsch, Chief Financial Officer, Member of the Management Board (Age 55)
  • Hartmut Klusik, Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director (Age 60)
  • Jennifer Brendelto, Vice President - Communications of the Consumer Health Division
  • Liam Condon, Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit (Age 48)
  • Kemal Malik, Member of the Management Board, Innovation and the Latin America Region (Age 54)
  • Erica Mann, Member of the Management Board, Head of the Consumer Health Division (Age 59)
  • Dieter Weinand, Member of the Management Board, Head of the Pharmaceuticals Division (Age 56)

How do I buy Bayer stock?

Shares of Bayer can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer's stock price today?

One share of Bayer stock can currently be purchased for approximately $32.05.

How big of a company is Bayer?

Bayer has a market capitalization of $105.24 billion and generates $51.77 billion in revenue each year. Bayer employs 115,200 workers across the globe.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]


MarketBeat Community Rating for Bayer (BAYRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  173 (Vote Outperform)
Underperform Votes:  216 (Vote Underperform)
Total Votes:  389
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer (OTCMKTS:BAYRY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.752.802.83
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Bayer (OTCMKTS:BAYRY) Consensus Price Target History

Price Target History for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
9/25/2017BNP ParibasUpgradeNeutral -> OutperformView Rating Details
7/3/2017Berenberg BankDowngradeBuy -> HoldView Rating Details
2/24/2017Sanford C. BernsteinReiterated RatingOutperformView Rating Details
1/4/2017JPMorgan Chase & Co.UpgradeNeutral -> OverweightView Rating Details
12/19/2016Jefferies GroupUpgradeHold -> BuyView Rating Details
9/14/2016Goldman Sachs GroupReiterated RatingBuyView Rating Details
8/25/2016CitigroupUpgradeNeutral -> BuyView Rating Details
5/25/2016CommerzbankUpgradeHold -> BuyView Rating Details
5/25/2016Deutsche BankReiterated RatingBuyView Rating Details
5/25/2016DZ BankReiterated RatingBuyView Rating Details
4/27/2016Credit Suisse GroupDowngradeOutperform -> NeutralView Rating Details
4/8/2016Nord/LBReiterated RatingBuyView Rating Details
3/7/2016BarclaysUpgradeUnderweight -> Equal WeightView Rating Details
(Data available from 1/21/2016 forward)

Earnings

Bayer (OTCMKTS:BAYRY) Earnings History and Estimates Chart

Earnings by Quarter for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS BAYRY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018        
10/26/2017Q3 2017$0.29$0.43ViewN/AView Earnings Details
7/27/20176/30/2017$1.87$1.99$14.45 billion$13.41 billionViewN/AView Earnings Details
4/27/20173/31/2017$2.40$2.80$13.65 billion$14.11 billionViewN/AView Earnings Details
10/26/2016Q3$1.80$1.93$12.39 billion$12.57 billionViewListenView Earnings Details
7/27/2016Q2 2016$0.55$0.59ViewN/AView Earnings Details
4/26/2016Q1 2016$0.62$0.65ViewN/AView Earnings Details
2/25/2016Q4 2015$0.33$0.29ViewN/AView Earnings Details
10/29/2015Q3$1.65$1.88$12.79 billion$12.28 billionViewListenView Earnings Details
7/29/2015Q2 2015$0.51$0.55ViewN/AView Earnings Details
4/30/2015Q1 2015$2.35$2.33$12.81 billion$13.45 billionViewN/AView Earnings Details
2/26/2015Q4 2014$1.35$12.53 billionViewN/AView Earnings Details
10/30/2014Q3 2014$0.43ViewN/AView Earnings Details
7/30/2014Q2 2014$2.05$14.02 billionViewN/AView Earnings Details
4/24/2014Q1 2014$2.47$2.35$14.67 billion$14.59 billionViewN/AView Earnings Details
2/28/2014Q4 2013$0.38ViewN/AView Earnings Details
10/31/2013Q3 2013$0.42ViewN/AView Earnings Details
7/31/2013Q2 2013$0.51ViewN/AView Earnings Details
4/25/2013Q1 2013$0.55ViewN/AView Earnings Details
2/28/2013Q4 2012$0.37$0.32ViewN/AView Earnings Details
10/30/2012Q3 2012$0.38ViewN/AView Earnings Details
7/31/2012Q2 2012$0.47ViewN/AView Earnings Details
4/26/2012Q1 2012$0.56ViewN/AView Earnings Details
2/28/2012Q4 2011$0.32$0.33ViewN/AView Earnings Details
10/26/2011Q3 2011$0.34$0.39ViewN/AView Earnings Details
7/28/2011Q2 2011$0.38$0.47ViewN/AView Earnings Details
4/27/2011Q1 2011$0.32$0.28ViewN/AView Earnings Details
2/28/2011Q4 2010$0.33ViewN/AView Earnings Details
11/1/2010Q3 2010$0.11ViewN/AView Earnings Details
7/30/2010Q2 2010$0.33$0.20ViewN/AView Earnings Details
4/29/2010Q1 2010$0.40ViewN/AView Earnings Details
11/23/2009Q3 2009$0.21$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Bayer (OTCMKTS:BAYRY) Earnings Estimates

Current Year EPS Consensus Estimate: $2.14 EPS
Next Year EPS Consensus Estimate: $2.48 EPS

Dividends

Bayer (OTCMKTS:BAYRY) Dividend Information

Most Recent Dividend:5/15/2017
Annual Dividend:$0.54
Dividend Yield:1.68%
Payout Ratio:25.23% (Based on This Year's Estimates)
21.77% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/29/2017Annual$2.165/1/20175/3/20175/15/2017
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Bayer (OTCMKTS BAYRY)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Bayer (OTCMKTS BAYRY) News Headlines

Source:
DateHeadline
Bayer AG (BAYRY) to Post FY2022 Earnings of $2.94 Per Share, Jefferies Group ForecastsBayer AG (BAYRY) to Post FY2022 Earnings of $2.94 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - January 18 at 11:58 PM
Bayer (BAYRY) Cut to Hold at Zacks Investment ResearchBayer (BAYRY) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - January 18 at 9:58 PM
Bayer AG Expected to Post FY2017 Earnings of $1.97 Per Share (BAYRY)Bayer AG Expected to Post FY2017 Earnings of $1.97 Per Share (BAYRY)
www.americanbankingnews.com - January 18 at 7:14 AM
Bayer (BAYRY) Upgraded at Zacks Investment ResearchBayer (BAYRY) Upgraded at Zacks Investment Research
www.americanbankingnews.com - January 17 at 11:26 PM
Why This Biotech Stock Is Diving Despite In-Line Liver Cancer ResultsWhy This Biotech Stock Is Diving Despite In-Line Liver Cancer Results
finance.yahoo.com - January 17 at 3:40 PM
Monsanto Displays Robust Growth Drivers Amid Headwinds - NasdaqMonsanto Displays Robust Growth Drivers Amid Headwinds - Nasdaq
www.nasdaq.com - January 14 at 4:11 PM
Monsanto Displays Robust Growth Drivers Amid HeadwindsMonsanto Displays Robust Growth Drivers Amid Headwinds
www.zacks.com - January 12 at 9:03 AM
Monsanto (MON) Q1 Earnings Top, Bayers Buyout Deal on Track - NasdaqMonsanto (MON) Q1 Earnings Top, Bayer's Buyout Deal on Track - Nasdaq
www.nasdaq.com - January 5 at 9:01 AM
Monsanto (MON) Q1 Earnings Top, Revenues Miss Estimates - NasdaqMonsanto (MON) Q1 Earnings Top, Revenues Miss Estimates - Nasdaq
www.nasdaq.com - January 4 at 10:40 AM
Monsanto (MON) Q1 Earnings Top, Revenues Miss EstimatesMonsanto (MON) Q1 Earnings Top, Revenues Miss Estimates
www.zacks.com - January 4 at 8:56 AM
Monsanto (MON) to Report Q1 Earnings: Whats in the Cards? - NasdaqMonsanto (MON) to Report Q1 Earnings: What's in the Cards? - Nasdaq
www.nasdaq.com - January 2 at 4:50 PM
3 Biggest Breakthroughs in Cancer Treatment in 2017 -- The Motley ... - Motley Fool3 Biggest Breakthroughs in Cancer Treatment in 2017 -- The Motley ... - Motley Fool
www.fool.com - December 30 at 3:41 PM
Roche Jumps Into Mergers and Acquisitions With $1.7 Billion Deal - Motley FoolRoche Jumps Into Mergers and Acquisitions With $1.7 Billion Deal - Motley Fool
www.fool.com - December 22 at 4:51 PM
Global Contraceptives Market 2017-2023 - The Market is Dominated by Allergan Plc, Bayer AG, Merck & Co., Teva Pharmaceutical, and Church & DwightGlobal Contraceptives Market 2017-2023 - The Market is Dominated by Allergan Plc, Bayer AG, Merck & Co., Teva Pharmaceutical, and Church & Dwight
www.prnewswire.com - December 22 at 6:07 AM
Monsanto Gives CEO Hugh Grant 64% Raise Ahead of Bayer AcquisitionMonsanto Gives CEO Hugh Grant 64% Raise Ahead of Bayer Acquisition
finance.yahoo.com - December 21 at 3:45 PM
BioMarins (BMRN) Gene Therapy Enters First Phase III Study - NasdaqBioMarin's (BMRN) Gene Therapy Enters First Phase III Study - Nasdaq
www.nasdaq.com - December 20 at 3:40 PM
ETFs with exposure to Bayer AG : December 14, 2017ETFs with exposure to Bayer AG : December 14, 2017
finance.yahoo.com - December 14 at 3:43 PM
Bayer AG (BAYRY) Given Consensus Recommendation of "Buy" by BrokeragesBayer AG (BAYRY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - December 11 at 1:48 AM
Bayer to Face EU Objections to Monsanto Deal in Coming DaysBayer to Face EU Objections to Monsanto Deal in Coming Days
finance.yahoo.com - December 8 at 3:40 PM
EU regulators to warn Bayer about Monsanto bid: sourceEU regulators to warn Bayer about Monsanto bid: source
finance.yahoo.com - December 8 at 3:40 PM
J&J, Bayer Ordered to Pay $29 Million in First Loss Over XareltoJ&J, Bayer Ordered to Pay $29 Million in First Loss Over Xarelto
finance.yahoo.com - December 5 at 12:26 PM
Antitrust reviews going into unimaginable depths, Bayer CEO says - Seeking AlphaAntitrust reviews going into 'unimaginable depths,' Bayer CEO says - Seeking Alpha
seekingalpha.com - November 29 at 4:08 PM
A Peek Into The Markets: U.S. Stock Futures Rise On Black Friday ... - BenzingaA Peek Into The Markets: U.S. Stock Futures Rise On Black Friday ... - Benzinga
www.benzinga.com - November 24 at 11:34 AM
Bayer Says INHALE Did Not Demonstrate Superiority - NasdaqBayer Says INHALE Did Not Demonstrate Superiority - Nasdaq
www.nasdaq.com - November 24 at 11:34 AM
Bayer Says INHALE Did Not Demonstrate SuperiorityBayer Says INHALE Did Not Demonstrate Superiority
www.rttnews.com - November 24 at 11:34 AM
Brazils review of Bayers Monsanto takeover may be extendedBrazil's review of Bayer's Monsanto takeover may be extended
finance.yahoo.com - November 22 at 5:03 PM
Bayer AG to Post FY2017 Earnings of $2.21 Per Share, Jefferies Group Forecasts (BAYRY)Bayer AG to Post FY2017 Earnings of $2.21 Per Share, Jefferies Group Forecasts (BAYRY)
www.americanbankingnews.com - November 20 at 3:44 AM
Is Loxo Oncologys Deal With Bayer Bad News? -- The Motley Fool - Motley FoolIs Loxo Oncology's Deal With Bayer Bad News? -- The Motley Fool - Motley Fool
www.fool.com - November 18 at 9:17 PM
Is Loxo Oncology's Deal With Bayer Bad News?Is Loxo Oncology's Deal With Bayer Bad News?
finance.yahoo.com - November 18 at 4:16 PM
Jefferies Group Comments on Bayer AGs FY2017 Earnings (BAYRY)Jefferies Group Comments on Bayer AG's FY2017 Earnings (BAYRY)
www.americanbankingnews.com - November 17 at 9:44 PM
Heres Why Nektar Therapeutics Is Skyrocketing 70% in NovemberHere's Why Nektar Therapeutics Is Skyrocketing 70% in November
www.fool.com - November 16 at 11:47 AM
Bayer AG (BAYRY) Receives Average Recommendation of "Buy" from BrokeragesBayer AG (BAYRY) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - November 16 at 1:32 AM
Bayer AG to Post FY2020 Earnings of $2.47 Per Share, Jefferies Group Forecasts (BAYRY)Bayer AG to Post FY2020 Earnings of $2.47 Per Share, Jefferies Group Forecasts (BAYRY)
www.americanbankingnews.com - November 15 at 4:28 PM
Monsanto (MON) Premium Herbicide Declared Non-Carcinogenic - NasdaqMonsanto (MON) Premium Herbicide Declared Non-Carcinogenic - Nasdaq
www.nasdaq.com - November 14 at 4:53 PM
Bayer Bets Big on a Tiny Cancer Drug Up-and-Comer - Motley FoolBayer Bets Big on a Tiny Cancer Drug Up-and-Comer - Motley Fool
www.fool.com - November 14 at 4:53 PM
Loxo Oncology to develop, commercialize cancer drugs with BayerLoxo Oncology to develop, commercialize cancer drugs with Bayer
finance.yahoo.com - November 14 at 4:53 PM
Loxo announces $400 mln Bayer cancer partnershipLoxo announces $400 mln Bayer cancer partnership
finance.yahoo.com - November 14 at 4:53 PM
Monsanto (MON) Premium Herbicide Declared Non-CarcinogenicMonsanto (MON) Premium Herbicide Declared Non-Carcinogenic
finance.yahoo.com - November 14 at 4:53 PM
Loxo signs lucrative cancer drug deal with Bayer, but shares fallLoxo signs lucrative cancer drug deal with Bayer, but shares fall
finance.yahoo.com - November 14 at 4:53 PM
This Cancer Biotech Is Falling On Its $1.55 Billion Bayer DealThis Cancer Biotech Is Falling On Its $1.55 Billion Bayer Deal
finance.yahoo.com - November 14 at 4:53 PM
Biotechs Sell Off In Droves — Are Investors Seeking Mergers?Biotechs Sell Off In Droves — Are Investors Seeking Mergers?
finance.yahoo.com - November 14 at 4:53 PM
ETFs with exposure to Bayer AG : November 13, 2017ETFs with exposure to Bayer AG : November 13, 2017
finance.yahoo.com - November 14 at 1:36 AM
Monsanto: Important To National Security? (Lawmakers Against Acquisition Say Yes)Monsanto: Important To National Security? (Lawmakers Against Acquisition Say Yes)
seekingalpha.com - March 20 at 10:00 AM
Roche Restructuring Shows Trouble in US Diabetes Biz (RHHBY)Roche Restructuring Shows Trouble in US Diabetes Biz (RHHBY)
www.investopedia.com - March 17 at 4:29 PM
Roche Restructuring Shows Trouble in US Diabetes BizRoche Restructuring Shows Trouble in US Diabetes Biz
www.investopedia.com - March 17 at 4:29 PM
CRISPR Therapeutics and JV with Bayer nab non-exclusive rights to MaxCytes cell engineering platformCRISPR Therapeutics and JV with Bayer nab non-exclusive rights to MaxCyte's cell engineering platform
seekingalpha.com - March 14 at 3:44 PM
Dow Chemical Subsidiary Must Pay $456 Million Award to BayerDow Chemical Subsidiary Must Pay $456 Million Award to Bayer
www.thestreet.com - March 2 at 4:03 PM
Trumps Anti-Pot Stance Wont Hurt This Canna-Business StockTrump's Anti-Pot Stance Won't Hurt This 'Canna-Business' Stock
www.thestreet.com - March 2 at 4:03 PM
Bayer sells 11 pct of Covestro for 1.46 bln eurosBayer sells 11 pct of Covestro for 1.46 bln euros
us.rd.yahoo.com - March 1 at 3:48 PM
Bayer Looks Beyond Xarelto And Eylea - Seeking AlphaBayer Looks Beyond Xarelto And Eylea - Seeking Alpha
seekingalpha.com - February 28 at 12:10 PM

SEC Filings

Bayer (OTCMKTS:BAYRY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bayer (OTCMKTS:BAYRY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bayer (OTCMKTS BAYRY) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.